Edgen Article

Market

Themes

en

bg_edgen_ai

Markets Confusing? Ask Edgen Search.

Instant answers, zero BS, and trading decisions your future self will thank you for.

Try Search Now

Edgen

Recommend

UnitedHealth Group rated Buy with $330 price target (~20% upside). FY2025 rev $419.3B, Optum Rx growth engine, forward P/E 14.2x, ~$18B FCF guided. Full analysis on Edgen.

UnitedHealth Group Stock Analysis: Healthcare's Vertical Integration Powerhouse | Edgen

The United States healthcare system consumes approximately $4.8 trillion annually, representing roughly 17.5 percent of gross domestic product — a proportion that continues its multi-decade upward trajectory driven by an aging population, chronic disease prevalence, and pharmaceutical innovation. For managed care organizations, this spending growth creates a durable revenue tailwind that few other sectors can match. The Centers for Medicare and Medicaid Services projects national health expenditure growth of 5 to 6 percent annually through the end of the decade, outpacing nominal GDP growth and ensuring that the underlying volume of insured lives and medical transactions continues to expand. The policy environment in 2026 presents a mixed backdrop. Medicare Advantage enrollment has surpassed 33 million beneficiaries, representing over half of all Medicare-eligible individuals — a penetration rate that seemed aspirational just five years ago. This secular shift benefits large managed ca

·

Apr 20 2026

Boeing rated Speculative Buy with $260 PT (~25% upside). $682B backlog, FCF turns positive at $4.1B, 737 ramping to 42/month. High debt at $54.1B. Full turnaround analysis on Edgen.

Boeing Stock Analysis: Ortberg's Turnaround Bets $682B Backlog Against $54B Debt | Edgen

The global commercial aviation market enters mid-2026 in a state of structural undersupply that directly benefits Boeing despite its well-documented operational challenges. Global passenger traffic has recovered to pre-pandemic levels and continues growing at 4-5% annually, driven by emerging market expansion — particularly in India, Southeast Asia, and the Middle East — while the global commercial fleet faces a demographic cliff: thousands of aging 737NG and A320ceo aircraft must be replaced over the next decade to meet fuel efficiency mandates and airline fleet modernization plans. This supply-demand imbalance is reflected in the order books. Boeing ($BA) and Airbus collectively hold backlogs exceeding $1.2 trillion, with delivery schedules stretching beyond 2035. Airlines cannot simply switch orders between manufacturers — engine selections, pilot training programs, and maintenance infrastructure create deep switching costs that lock customers into platform families. For Boeing, thi

·

Apr 20 2026

AbbVie rated Buy with $250 PT. FY2025 rev $61.16B (+10.6%), Skyrizi+Rinvoq $27B run rate, FCF $17.8B, Dividend Aristocrat. Full analysis on Edgen.

AbbVie Stock Analysis: Skyrizi & Rinvoq Redefine the Pharma Thesis | Edgen

The global pharmaceutical industry in 2026 is navigating a structural transformation driven by three converging forces: the largest patent cliff cycle in the sector's history, the implementation of the Inflation Reduction Act's drug price negotiation provisions, and a widening bifurcation between companies with genuine innovation engines and those reliant on mature, commoditizing portfolios. Between 2023 and 2030, branded drugs representing over $250 billion in peak annual revenue will lose patent protection, exposing companies to biosimilar and generic competition that typically erodes 60-80% of branded revenue within three to five years of exclusivity loss. AbbVie's Humira, which peaked at $21.2 billion in annual sales in 2022 as the world's best-selling drug, was the poster child for this risk. The drug's U.S. biosimilar entry in January 2023 triggered an immediate and sustained revenue decline — Humira revenue fell to approximately $14.4 billion in FY2023, then approximately $10.2

·

Apr 20 2026

ETH rated Buy with $3,200 PT (~38% upside from $2,325). Ultra sound money thesis, $175.8B TVL, EIP-4844 L2 scaling, RWA tokenization via BlackRock BUIDL, ETH ETF catalyst. Full crypto analysis on Edgen.

Ethereum (ETH) Analysis: Layer 2 Supercycle & RWA Tokenization | Edgen

The cryptocurrency market in mid-April 2026 exists at a peculiar intersection of institutional validation and operational fragility. The approval of spot Ethereum ETFs has opened a regulated pipeline for traditional capital to gain ETH exposure, while BlackRock's BUIDL fund and Franklin Templeton's blockchain-native treasury products signal that the world's largest asset managers view Ethereum not as a speculative token but as financial infrastructure. Yet the Kelp DAO bridge exploit on April 19 — which compromised 116,500 rsETH and propagated $196 million in bad debt through Aave V3 and SparkLend — demonstrated that the composability which makes Ethereum's ecosystem powerful also makes it fragile when any single component fails. The Kelp incident is particularly relevant for Ethereum holders because it tested not the base layer's security but the restaking and liquid staking derivatives infrastructure built on top of it. Approximately 35 million ETH are staked, and a growing share of

·

Apr 20 2026

AAVE rated Buy with $160 PT (~42% upside). Kelp DAO hack created $196M bad debt but Aave contracts uncompromised. Fee switch activated, V4 catalyst ahead. Full DeFi analysis on Edgen.

AAVE Analysis: DeFi Lending After the Kelp Hack | Edgen

Decentralized finance in the spring of 2026 operates in a fundamentally different environment than the speculative frenzy of 2021 or the existential crisis of 2022. Total value locked across all DeFi protocols has stabilized above $100 billion, institutional participation is no longer experimental, and revenue-generating protocols have replaced yield-farming ponzis as the sector's center of gravity. Yet the Kelp DAO exploit on April 19 exposed a vulnerability that the industry has discussed theoretically for years but never experienced at this scale: the systemic risk that cross-chain bridge failures can propagate through composable DeFi protocols and create contagion in systems that were never themselves compromised. The attack vector was not a flaw in Aave's lending logic, its liquidation engine, or its oracle infrastructure. It was a flaw in Kelp's cross-chain bridge — a separate protocol that issues rsETH, a liquid restaking token representing staked Ethereum. Attackers exploited t

·

Apr 20 2026

GE Aerospace rated Buy with $340 PT. $190B backlog, FCF $7.7B, LEAP engine ramp, 26.6% CES margin. Full analysis on Edgen.

GE Aerospace Stock Analysis: FLIGHT DECK Drives the Ascent | Edgen

The global aerospace and defense sector enters mid-2026 at a structural inflection rarely seen in peacetime. Commercial aviation traffic has fully recovered to pre-pandemic levels, and both Boeing ($BA) and Airbus are working through record order backlogs that stretch delivery schedules to the end of the decade. The International Air Transport Association (IATA) projects global passenger traffic growth of 4–5% annually through 2030, driven by emerging market middle-class expansion and fleet modernization requirements. Simultaneously, NATO defense spending commitments — now targeting 2.5% of GDP across the alliance — have created a parallel demand tailwind for military propulsion and advanced combat engine programs. For GE Aerospace, this dual-engine macro environment is structurally favorable. The company's Commercial Engines & Services (CES) segment benefits directly from both new aircraft deliveries and the aftermarket services revenue that accelerates as the installed base of LE

·

Apr 20 2026

Intel rated Spec Buy with $80 PT. IDM 2.0 foundry pivot under Lip-Bu Tan. 18A node in qualification, CHIPS Act $19.5B secured. Full analysis on Edgen.

Intel Stock Analysis: The Foundry Turnaround Bet | Edgen

The global semiconductor industry entered 2026 in the midst of a bifurcated cycle. AI-related demand — accelerators, high-bandwidth memory, advanced packaging — continues to surge, with TSMC ($TSM) reporting Q1 2026 revenue of $35.9 billion (+35% YoY) and high-performance computing comprising 61% of sales. Meanwhile, the traditional PC and server CPU markets are transitioning from a multi-year digestion period into the early stages of a refresh cycle, driven by Windows 11 end-of-support timelines and enterprise AI PC adoption. This bifurcation creates a specific opening for Intel: its core client CPU business benefits from the PC refresh, while its foundry ambitions target the structural shortage of geographically diversified leading-edge manufacturing capacity. The geopolitical dimension cannot be overstated. The CHIPS and Science Act, signed into law in August 2022, represents the United States' most significant industrial policy intervention in the semiconductor sector since the cre

·

Apr 20 2026

Tesla rated Hold with $380 PT (~10% upside). First revenue decline in history, margins compressed to 4.6%, but robotaxi, Optimus, and Energy Storage create massive optionality. Full analysis on Edgen.

Tesla Stock Analysis: Margins Compress as Robotaxi and Energy Optionality Grow | Edgen

The global electric vehicle industry entered 2026 in a fundamentally different competitive posture than the supply-constrained environment that defined Tesla ($TSLA)'s peak margin years of 2021-2022. Global EV penetration has crossed the 25% threshold in key markets including China and Western Europe, transitioning the sector from early adopter growth to mass-market competition where price, distribution density, and incremental feature differentiation determine market share. China, the world's largest EV market representing over 60% of global battery electric vehicle sales, has become a bloodbath for margins as dozens of domestic manufacturers — led by BYD, which surpassed Tesla in global EV deliveries in 2025 — compete on price, range, and technology refresh cadence. The macroeconomic backdrop adds complexity. Interest rates, while trending lower from their 2024 peaks, remain elevated relative to the near-zero environment that turbocharged EV demand in 2020-2021. Vehicle affordability

·

Apr 20 2026

Alcoa rated Buy with $95 PT. FY2025 rev $12.83B, ELYSIS carbon-free tech, Alumina Ltd acquisition. Aluminum demand from EVs and decarbonization. Full analysis on Edgen.

Alcoa Stock Analysis: The Green Aluminum Revolution | Edgen

The global aluminum market is entering a period of structural tightness that commodity investors have not witnessed in over a decade. On the demand side, the accelerating transition to electric vehicles is driving unprecedented appetite for lightweight aluminum in battery enclosures, body panels, and structural components. Each battery electric vehicle contains roughly 250 kilograms of aluminum, approximately 60 percent more than a comparable internal combustion engine vehicle. Simultaneously, renewable energy infrastructure buildouts — from solar panel frames to wind turbine housings — are creating durable, non-cyclical demand streams that overlay the traditional construction and packaging end markets. On the supply side, the policy landscape is tilting decisively in favor of Western producers. The United States maintains a 10 percent tariff on aluminum imports, with Section 232 duties providing a protective umbrella for domestic smelters. Perhaps more consequential is the European Un

·

Apr 17 2026

AMD rated Buy with $310 PT. TSMC blowout validates AI demand. Data Center +60% CAGR, MI400 incoming, server CPU share 36%. Full analysis on Edgen.

AMD Stock Analysis: TSMC's AI Blowout Validates the Bull Case | Edgen

The semiconductor industry entered 2026 navigating a complex cross-current of surging AI infrastructure demand and lingering geopolitical friction around China export controls. On April 17, Taiwan Semiconductor ($TSM) reported Q1 2026 revenue of $35.9 billion, representing 35% year-over-year growth that significantly exceeded consensus expectations. More telling than the headline figure was the composition: high-performance computing — the segment encompassing AI accelerators, server CPUs, and 5G infrastructure — accounted for 61% of total revenue, up from approximately 52% in the year-ago quarter. TSMC's gross margin of 66.2% and operating margin of 58.1% underscored that this AI-driven demand is not just voluminous but structurally higher-margin. The company guided Q2 revenue to $39–40.2 billion, implying a further 10% sequential acceleration. For AMD, TSMC's results function as an independent demand signal. AMD is a fabless semiconductor company — it designs chips but outsources man

·

Apr 17 2026

GetStock Picks
that actually win